fashion -WSS

fashion

author：hotspot 2025-09-02 11:48:37 - browse：81492

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. – health care policy coverage from STAT — Medicare has a new proposal to pay hospitals more to stockpile essential drugs, an effort to avoid shortages of chemotherapies and other drugs. Jenny Kane/AP

WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs — an idea that comes as doctors report running low on critical chemotherapies and other drugs. But experts caution the policy could cause the very shortages that government officials are trying to avoid.

For years most of the solutions for addressing drug shortages have involved giving the Food and Drug Administration more power. During the Covid-19 pandemic, Congress empowered the FDA to make drug companies create backup plans for manufacturing facility interruptions, and to collect information from drug makers on where they source ingredients. The FDA also has the authority to prioritize reviews of applications for drugs in short supply and to prioritize inspections of manufacturing facilities that plan to ramp up production.

But Medicare has its own new idea: paying hospitals to create a “buffer stock” of 86 medicines that HHS deems critical. Medicare would not pay hospitals for the drugs. Rather, it would pay hospitals for the cost of managing a three-month inventory of the drugs. It published the proposal in a rule last week; it’s seeking comment now before it will weigh whether to finalize the policy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Hospital at home shows how to bring innovation to health care

WSS

Medicare slashes safety net hospital payments by nearly $1 billion

Trans patients at the end of life deserve respect and dignity

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

DeSantis wants to import drugs. Biden’s FDA blasted his plan

2 officers injured in shooting in Orlando, police say

Alnylam reports growth in sales of rare disease treatments

leisure time

fashion

entertainment

Heart attack and stroke risk calculators need revising

Health officials lay out plans to cope with respiratory virus season

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A controversial new treatment promises to make little people taller

As demand for Covid shots wanes, Moderna seeks its next success

FDA advisory panel to debate high blood pressure devices

Moonlake's readout produced a cash windfall. Risks remain

PBMs are inflating the cost of generic drugs. They must be reined in

United colonoscopy coverage change 'may cost lives,' doctors say

FDA approves Sage Therapeutics’ rapid

knowledge

Republicans love RFK Jr. What's that tell us about health in 2024?

2 officers injured in shooting in Orlando, police say

Wegovy improves function in certain heart failure patients

FDA scientists endorse Pfizer/BioNTech Covid

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Meadows told special counsel he could not recall Trump ever declassifying Mar

entertainment

knowledge

focus

explore